764 related articles for article (PubMed ID: 29360467)
1. Parkinson's disease from the gut.
Liddle RA
Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
3. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
Holmqvist S; Chutna O; Bousset L; Aldrin-Kirk P; Li W; Björklund T; Wang ZY; Roybon L; Melki R; Li JY
Acta Neuropathol; 2014 Dec; 128(6):805-20. PubMed ID: 25296989
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.
Chandra R; Hiniker A; Kuo YM; Nussbaum RL; Liddle RA
JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614796
[TBL] [Abstract][Full Text] [Related]
6. [The role of alpha-synuclein in Parkinson's disease].
Miklya I; Pencz N; Hafenscher F; Göltl P
Neuropsychopharmacol Hung; 2014 Jun; 16(2):77-84. PubMed ID: 24978050
[TBL] [Abstract][Full Text] [Related]
7. Modeling Lewy pathology propagation in Parkinson's disease.
Luk KC; Lee VM
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
9. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
Chen M; Mor DE
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
[TBL] [Abstract][Full Text] [Related]
10. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
Negi S; Khurana N; Duggal N
Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
[TBL] [Abstract][Full Text] [Related]
11. The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease and Its Counterpart in Peroral Prion Infections.
Beekes M
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372600
[TBL] [Abstract][Full Text] [Related]
12. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.
Wakabayashi K; Tanji K; Mori F; Takahashi H
Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486
[TBL] [Abstract][Full Text] [Related]
13. Targeting alpha-synuclein for the treatment of Parkinson's disease.
Rohn TT
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):174-9. PubMed ID: 22483285
[TBL] [Abstract][Full Text] [Related]
14. What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
Dunning CJ; George S; Brundin P
Prion; 2013; 7(1):92-7. PubMed ID: 23360753
[TBL] [Abstract][Full Text] [Related]
15. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
16. Prion-like propagation of pathology in Parkinson disease.
Volpicelli-Daley L; Brundin P
Handb Clin Neurol; 2018; 153():321-335. PubMed ID: 29887143
[TBL] [Abstract][Full Text] [Related]
17. [Ascendance of Abnormal α-synuclein Fibrils Through the Vagal Nerve in Parkinson's Disease].
Ohno K; Hirayama M
Brain Nerve; 2022 Aug; 74(8):979-984. PubMed ID: 35941794
[TBL] [Abstract][Full Text] [Related]
18. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.
Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M
Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878
[TBL] [Abstract][Full Text] [Related]
19. [Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].
Wakabayashi K
Rinsho Shinkeigaku; 2008 Nov; 48(11):981-3. PubMed ID: 19198138
[TBL] [Abstract][Full Text] [Related]
20. [Prion Properties of Alpha-Synuclein].
Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
